The effects of intraventricular injections of quaternary ammonium compounds on the acetylcholine content of rat brain.
D000109:Acetylcholine / Q000096:biosynthesis / Q000378:metabolism*; D000818:Animals; D001921:Brain / Q000187:drug effects; D003864:Depression, Chemical; D005260:Female; D006426:Hemicholinium 3 / Q000494:pharmacology; D008526:Medulla Oblongata / Q000378:metabolism; D008636:Mesencephalon / Q000378:metabolism; D009020:Morphine / Q000494:pharmacology; D009025:Morpholines / Q000494:pharmacology*; D010424:Pentobarbital / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D011149:Pons / Q000378:metabolism; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D051381:Rats; D013757:Tetraethylammonium Compounds / Q000494:pharmacology*
D009025:Morpholines; D000644:Quaternary Ammonium Compounds; D013757:Tetraethylammonium Compounds; D006426:Hemicholinium 3; D009020:Morphine; D010830:Physostigmine; D010424:Pentobarbital; D000109:Acetylcholine